New Hope for Alzheimers Treatment
There is now widespread agreement among research scientists and medical professionals that Alzheimer's Disease (AD) is a problem quickly growing to vast proportions. As the life expectancy of Americans continues to rise, increasing the percentage of the population over 65 years of age, so does the number of Alzheimer's cases.
It is currently estimated that people over 65 years of age have a 10% chance of developing Alzheimer's, while those over 85 have a 50% likelihood of developing AD, making it the leading cause of dementia among older people. Though the disease is associated primarily with memory loss, its effects also comprise a number of other severe disabilities, including changes in personality, disorientation, difficulty with speech and comprehension, and a lack of ability to move normally.
Consequently, most Alzheimer's patients require a great deal of care, costing society close to $100 billion annually. According to Christian Fritze, Ph.D., Director of the Antibody Products Division at Covance Research Products, "The impact of Alzheimer's Disease on our society will only increase as our population ages. The prevalence of the disease and disabling effects on the patient are significant by themselves. In addition we are becoming increasingly aware of the far-reaching effects on families, care-giver networks and the economics of our health care system. The drive for progress towards effective treatments by the research and drug development community is growing stronger every day."
A New Consensus
But recent developments in the medical research community do provide some hope. During the last two years, there has been a growing consensus among Alzheimer researchers about the cause of Alzheimer's disease, providing focus for scientists exploring the new treatment options.
The focus is on amyloid beta oligomers, a new wrinkle on an older hypothesis called the "amyloid cascade hypothesis". Widespread acceptance of this new conclusion is something of a milestone in the history of Alzheimer's research. As Dr. Fritze says, "The decades old quest for the causative agent in Alzheimer's Disease has recently focused on the precursors of amyloid plaques. These precursors are part of a bewildering array of processed (APP) Amyloid Precursor Protein) variants, Tau isoforms and secretase components that play a role in neuronal cytotoxicity and subsequent brain dysfunction."
Amyloid plaques are sticky protein deposits in the brain containing amyloid beta peptide. Researchers have associated the buildup of this plaque with Alzheimer's disease since its discovery in 1907. But despite the clear correlation, scientists were not sure what, exactly, spurred the onset of Alzheimer's Disease.
The hypothesis that amyloid beta accumulation in the brain is the major cause of Alzheimer's Disease1 has been the focus of much attention over the past decade. Although this hypothesis was the leading explanation for the cause of AD, it had several weaknesses. The most obvious problem with the theory was the fact that the buildup of amyloid beta peptides did not necessarily correspond with the severity of Alzheimer's symptoms.
However, in 19982 and in 20023, researchers proposed that it was not the amyloid beta plaques themselves that were neurotoxic - and therefore the cause of Alzheimer's - but rather precursors to amyloid beta plaques formed by smaller aggregates of amyloid beta. These new ideas are gaining widespread acceptance among the Alzheimer's research community, creating a consensus that had not existed before.
This new focus provides one more spur to action for Alzheimer's researchers, and underscores the need for further advancement. "The AD field demands sophisticated, highly-sensitive research tools to track these components and quantitate the existence of monomeric, oligomeric and fibrillar amyloid forms present in the progression of Alzheimer's disease," says Dr. Fritze.
Two new studies, both released in October 20044, suggest that new treatment options may be on the horizon. The studies are the modification of one of two previous attempts using amyloid beta (Aβ) antibodies in the treatment of Alzheimer's Disease. The previous attempts, though not successful, did at least suggest new courses of action in Alzheimer's research and provided invaluable information for researchers.
In the first of the two previous attempts, researchers injected the antigen itself - pieces of the beta amyloid protein that makes up amyloid plaque - into mice, in the hopes that the injections would generate an immune (antibody) response against amyloid. Results were initially positive. The injected antigen produced Aβ antibodies and slowed the onset of the disease by decreasing Aβ levels. However, when tried on humans, the procedure led to meningoencephalitis (an inflammation of tissue around the brain) in some patients, and was therefore halted.
In the second attempt, a passive immunity therapy was tried in which antibodies to amyloid beta (not amyloid protein) were injected into mice, but hemorrhaging and inflammation ensued due to the high antibody doses required to be effective.
But now there appears to be new hope for the use of antibodies as therapeutic agents for the treatment of Alzheimer's patients. In the first of the two new studies that appeared in October conducted by the National Institute for Longevity Sciences, NCGG, and the Center for Neurological Diseases, Brigham & Women's College, Harvard Institute of Medicine, researchers modified the first procedure. Concluding that the meningoenchaphalitis which occurred in some patients was caused by autoimmune T-cell activation, the researchers hoped to develop a vaccine that could minimize this T-cell activation while retaining the production of Aß antibodies.
To accomplish this they created an oral vaccine that attached Aß DNA to an adeno-associated virus vector, which served to mitigate T-cell activation. Thus they were able to decrease Aß levels in the brains of the mice and yet not activate T-cells to the degree they had before, greatly reducing the risk of meningoencephalitis.
In the other new study, conducted at the University of Illinois at Chicago, researchers succeeded in making the passive immunity protocol much safer. This they accomplished by changing the point of entry for the Aß antibodies. Rather than injecting the antibodies into the body of the mice, as was done previously, antibody was injected directly into the brain of the mice. Because the antibodies were injected directly into the brain, smaller doses were needed, and side effects were minimized.
The results of the above studies, and the potential for further optimized immunization strategies may prove to be watershed events in the history of Alzheimer's treatment.
Covance is a leading provider of innovative antibody products and custom antibody development services to the research community for Alzheimer's disease. Visit www.Covance.com for more in-depth information and to view the suite of products for Alzheimer's disease. Boris Predovich is Vice President of Immunology and Surgical Services at Covance Research Products.
1. J.A. Hardy, G.A. Higgins (1992), Science, 256:184-5.
R. L. Fielding writes on many health-related topics.
Long Term-Care; 70 Million Americans Will Be Over 65 by 2003
We will all grow old; this is a given. We will all have health issues as we grow older, this also is a given.
Stair Lift Buying Guide
There is no doubt that having a stair lift in your home can dramatically improve your quality of life. If you are starting to find that climbing the stairs is becoming a hazardous experience, or just hard work, then a stair lift could be the answer.
Prepare to Make Long-term Care Choices
Several months ago, I was coming out of a gas station when a woman stopped me and asked me what I did for a living. On the back of our van is our web address.
Retiring Abroad and Leaving the Grey Skies of the UK
Retiring abroad needs careful planning. Not all countries have the same entitlement to benefits as the UK and your tax liability may be affected.
Angels Are Reaching Out to the Elderly
I am reminded time after time of the profound effect Angels have on people. Recently, I have been receiving many emails containing examples of how the Angels are reaching through the veils to assist the elderly.
Short Trips Can Stimulate Alzheimers Patients
Severe degradation of short-term memory means that my father, an Alzheimer's elder, is seldom interested in movies or books. And, although music used to be a source of enjoyment, he no longer listens with pleasure.
Solitary Confinement -- for Life
Sixty-five year old Arthur Jones served a self-imposed life sentence - in his own home.Arthur lived in a high crime neighborhood, so he built iron cages around his outside doors and installed bars on all the windows.
Local Businesses Serving Seniors Prove Commitment to Quality Care
Good news! You no longer have to risk chance when it comes to selecting a reputable elder care service for yourself or for a loved one. Senior Approved Services has certified a select number of businesses in our area serving the elderly and disabled populations.
Mom Wont Participate!
Q: Six months ago we placed my mother in an assisted living facility. She gets along fairly well, but we thought she would get involved with all of the activities.
Senior Living: 5 Ways to Help Reduce the Risk of Falling
Every year we hear stories of seniors falling, ending up in hospitals and never fully recovering. Unfortunately, these falls often result in death.
Honey, Where Are The Car Keys?
Q: My mother is always losing, hiding and hoarding things, I am losing my mind! What can I do to get her to stop?A: This is a great question and I have a lot of material to work with.My grand mother had made me the most beautiful doilies.
How To Find Affordable Senior Housing
A few years ago Miranda M. became a widow.
When the Box is Empty
The King had a modest kingdom. He was Danish.
The Dryer Ate Your Underwear!
Q: My mom is in the early stages of dementia and she is also incontinent we have tried to get her to stop wearing her underpants and have her start wearing pull-up diapers, she throws the Depends out the door and puts her underpants on. Of coarse we have a lot of laundry! How should I handle this?A: This one should be fairly easy to solve.
Second Hand Stair Lifts
Buying second hand stair lifts is a viable and cost effective alternative to purchasing a brand new stair lift. Most stair lifts can be purchased new or second hand.
Advocate For Senior Citizens - Protecting Against Abuse and Fraud
Ruth is 87 years old this year and has been living alone since 1997. She is in good health, however the daily chores around the home became increasingly difficult.
Compare Nursing Homes
Finding the best nursing home is easier than you might think. That is assuming there is more than one nursing home in your area so that you have something to compare.
Long Term In-home Care Options
Are you worried that you may lose all your life's earnings and nest egg due to the rising costs of in-home long term care? As you get older do you have the necessary finances to protect yourself from going broke while slightly incapacitated? Many seniors are worried about are worried about the costs of long-term health care.Are you worried that if something happens to you, that you may run out of money and burn thru their reserves and all your nest egg.
As the Baby Boomers Age
Many employees today are calling in sick - not to care for themselves or their children, but to care for their aging parents. Baby boomers are rapidly moving into the role of caregivers for their parents, but with a few extra challenges due to the changing face of our workforce.
The Golden Years
1) What does Adrian Mitchell say we do to people when their working lives are over?Adrian says that "when a man's too ill to work we punish him", rob him of half his income or replace it with "pocket money" and or place him in a retirement home to sit out the remainder of his live in isolation.2) What does he think about this?Adrian thinks that "the old people are being robbed" and says "to hell with retiring" he believes that the way that deal with old people (to have your ability to sport yourself removed and then being given "pocket money").
|home | site map|